Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Independent Global Neurotech. Institute | Main | Supreme Court Upholds Right to Refuse Mind-Altering Drugs »

June 13, 2003

Free Will or Free Willy?

Email This Entry

Posted by Zack Lynch

PlumpJack's delicious duck dinner had a hard time competing with tonight's table conversation concerning free will.  For about two hours Paul Zak, Paul Glimcher, Howard Fields, Oliver Goodenough, Margaret Gruter, Kevin McCabe, Morris Hoffman, and myself wrestled with randomness, arrows in time, coin flipping, converging utility maps, selective evolutionary tendencies, cheek pinching, dopamine neurons, motivation, oxytocin, synesthesia and yes, even whales.


Today's talks were outstanding and when time permits and connection speeds are faster the data dump will flow. Until then, it's all good food for thought and pleasant dreams.

Comments (0) | Category: X-tra



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives